Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the ...
STAT
Merck’s heart disease win and the FDA’s new drug regulator
What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?
Blockonomi
Merck (MRK) Stock: Heart Drug Trial Results Push Shares Up
Shares rise 8.5% on enlicitide decanoate Phase 3 data showing LDL reduction. Q3 earnings beat at $2.58/share with $17.3B ...
BioPharma Dive
Blackstone pays Merck $700M to buy into ADC drug royalties
The deal hands Blackstone a piece of the potential future sales of an antibody-drug conjugate that could soon challenge marketed medicines from AstraZeneca and Gilead.